Alistair G. Robertson
Courtenay, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Explainable machine learning prediction of functional independence measure scores and gain in subacute stroke survivors.
Journal: Journal of neuroengineering and rehabilitation
Published: November 12, 2025
Protocol for obtaining cancer type and subtype predictions using subSCOPE.
Journal: STAR protocols
Published: December 01, 2024
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Journal: Cell reports
Published: April 05, 2024
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
Journal: Research square
Published: January 30, 2023
The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
Journal: Oncogene
Published: December 28, 2022
Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.
Journal: Nature communications
Published: December 23, 2022
Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Journal: Science advances
Published: October 05, 2022
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.
Journal: Bioinformatics (Oxford, England)
Published: September 07, 2022
Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling.
Journal: Cancer research communications
Published: July 13, 2022
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.
A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.
Journal: Scientific reports
Published: April 14, 2022
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Journal: Nature communications
Published: December 12, 2021
Last Updated: 09/26/2026